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Abstract
The dose-response relation is a well-established finding in the general psychotherapy literature.
Investigators from this literature define the dose-response relation as how much face-to-face
treatment is needed to realize a statistically reliable improvement in psychological symptoms.
However, there is presently mixed evidence on the presence of a dose-response relation in the
literature on face-to-face psychological treatment for gambling disorder. In the present study,
meta-regression was employed to synthesize results from past studies on the efficacy of
psychological treatment for gambling disorder to determine the possible presence of a doseresponse relation in those treatments. The hypothesis was that there was no dose-response
relation in face-to-face psychological treatments for gambling disorder. This meta-analysis
included 8 studies representing varying treatment doses and 592 clients. Across the 8 studies, the
results of a meta-regression indicated that there was a dose-response relation in psychological
treatments for gambling disorder. The results suggest that clinicians should retain clients in these
treatments as long as possible to maximize therapeutic benefit. Future research would benefit
from high-quality randomized controlled trials designed to test treatment efficacy at doses larger
than six sessions.
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Introduction
Investigators of studies from the general psychotherapy literature suggest that there is a
dose-response relation in face-to-face psychological treatments. However, there is mixed
evidence for the presence of a dose-response relation in face-to-face treatments for gambling
disorder. Comprehensive reviews have supported the efficacy of cognitive-behavioral therapy
(CBT) and motivational interventions for gambling disorder (e.g., Cowlishaw et al., 2012; Petry,
Ginley, & Rash, 2017; Yakovenko, Quigley, Hemmelgarn, Hodgins, & Ronksley, 2015). In
randomized controlled trials of head-to-head comparisons, several investigators have found that
one session of these treatments is as efficacious as multiple sessions (e.g., Larimer et al., 2012;
Petry, Weinstock, Morasco, & Ledgerwood, 2009; Toneatto, 2016). By contrast, other
investigators have suggested that a greater number of sessions may relate to enhanced
therapeutic outcome (e.g., Pfund, Peter, Whelan, & Meyers, 2018; Shaffer, LaBrie, LaPlante,
Kidman, & Donato, 2005; Smith, Battersby, Harvey, Pols, & Ladouceur, 2015). Taken together,
there is mixed evidence on whether there is a dose-response relation in psychological treatments
for gambling disorder. In the present study, meta-analysis was used to synthesize results from
past studies and to determine the possible presence of a dose-response relation in psychological
treatments for gambling disorder.
In the general psychotherapy literature, there is a dose-response relation in face-to-face
psychological treatments (Howard, Kopta, Krause, & Orlinsky, 1986). The dose-response
relation is defined as how much treatment is needed to realize a statistically reliable
improvement in psychological symptoms. Authors of the studies attesting to the dose-response
relation define dose as a session of face-to-face treatment and define response as the measured
changed on a standardized outcome measure. Hansen, Lambert, and Forman (2002) indicated
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that between 13-18 sessions were required for 50% of clients to demonstrate change in their
psychological symptoms. The rate of change within psychotherapy is not linear (Baldwin,
Berkeljon, Atkins, Olsen, & Nielsen, 2009; Hayes, Laurenceau, Feldman, Strauss, &
Cardaciotto, 2011), as the rate significantly varies based on factors such as outcome variables
(Owen, Adelson, Budge, Kopta, & Reese, 2016) and treatment settings (Falkenström, Josefsson,
Berggren, & Holmqvist, 2016). Studies on the dose-response relation in the general
psychotherapy literature capture many presenting complaints, such as depression and anxiety,
but it would be important to understand whether there is a dose-response relation in
psychological treatments for gambling disorder. If there is a dose-response relation in
psychological treatment for gambling disorder, then clinicians would be aided in determining
what constitutes an adequate dose of treatment.
Gambling disorder has been characterized by persistent and recurrent betting that results
in financial, psychological, relational, and vocational difficulties (American Psychiatric
Association, 2013). Across the globe, between 0.2% and 2.1% of adults develop gambling
disorder (Stucki & Rihs-Middel, 2007). An additional 0.5% to 4.0% of adults experience some
symptoms of gambling disorder, but do not reach a diagnosable level (Stucki & Rihs-Middel,
2007). Higher rates of these symptoms have been found in specific populations including but not
limited to college students (10%; Nowak & Aloe, 2014), and substance use disorder treatment
populations (20%; Cowlishaw, Merkouris, Chapman, & Radermacher, 2014).
Although a variety of psychological treatments have been employed for gambling
disorder and its subclinical symptoms, CBT and motivational interventions (e.g., motivational
interviewing, motivational enhancement therapy) have received the greatest evidence for
efficacy (Cowlishaw et al., 2012; Petry et al., 2017; Yakovenko et al., 2015). These treatments
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have been conducted predominately face-to-face over varying treatment lengths or doses (e.g.,
Carlbring, Jonsson, Josephson, & Forsberg, 2010; Petry et al., 2016) and have been conducted
with individuals, groups, couples, and families. Authors of meta-analyses have found
substantially larger posttreatment effect sizes when comparing multi-session treatments to no
treatment controls (d = 2.01; Pallesen, Mitsem, Kvale, Johnsen, & Molde, 2005) than for singlesession treatments to no treatment controls (d = 0.20; Peter et al., 2019).
Some evidence supports the presence of a dose-response relation in psychological
treatments for gambling disorder (Pfund et al., 2018; Shaffer et al., 2005; Smith et al., 2015). For
example, in a randomized controlled trial, Smith and colleagues (2015) compared outcomes
between treatment dropouts and treatment completers across 12-sessions of cognitive therapy
and exposure therapy and found that treatment completers evidenced significantly greater
symptom improvement than treatment dropouts. Those results would indicate that there is a
positive dose-response relation in psychological treatment for gambling disorder. That is,
attending a greater number of sessions enhances therapeutic outcomes.
Other evidence does not support the presence of a dose-response relation in psychological
treatments for gambling disorder. Several investigators have suggested that therapeutic outcomes
are equivalent between single-session treatments and multi-session treatments (e.g., Larimer et
al., 2012; Petry et al., 2009; Toneatto, 2016). For example, Petry and colleagues (2009) found
equivalent posttreatment outcomes among participants who were randomly assigned to one
session of brief advice, one session of motivational enhancement therapy, or one session of
motivational enhancement therapy plus three sessions of CBT (four sessions total). However, it
is important to note that investigators of these studies based their conclusions on a
prescribed/offered dose rather than the actual dose that participants received or attended. All
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participants (100%) who were assigned to brief advice or motivational enhancement therapy in
the study by Petry and colleagues (2009) actually received the full one session dose, but only
33% of participants who were assigned to motivational enhancement therapy plus CBT received
the full four session dose. In other words, the investigators of these past studies did not examine
the relation between the number of sessions that participants actually received/attended and
therapeutic outcome.
Given the mixed evidence on the presence of a dose-response relation in the
psychological treatment for gambling disorder, a meta-analysis was conducted to provide a
quantiative synthesis of the results from past randomized controlled trials. Specifically, a metaanalysis was performed on the received treatment dose (i.e., the average number of treatment
sessions that participants actually attended) and efficacy from these trials. Meta-regression was
used to identify the possible relation between the received treatment dose and treatment efficacy.
The hypothesis was that there was no dose-response relation in psychological treatment for
gambling disorder. Methodological limitations of the randomized controlled trials included in
this meta-analytic review may impact the overall conclusions about the dose-response relation.
Thus, an assessment of study quality was conducted using the Cochrane risk of bias tool
(Higgins & Green, 2011) to evaluate the validity of conclusions.
Method
This review included studies published through June 2018 and used PRISMA guidelines
(Moher, Liberati, Tetzlaff, & Altman, 2009). Searches were performed in PsychINFO and
PUBMED with the following combination of search terms: (“therapy” OR “treatment” OR
“intervention”) AND (“gambl*”). Secondary reference searching was conducted on all studies
yielded from the initial search. That secondary reference searching included a Cochrane review
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of psychological treatments for gambling disorder (Cowlishaw et al., 2012) and the most recent
systematic review of psychological treatments for gambling disorder (Petry et al., 2017).
Inclusion and Exclusion Criteria
Studies were included in this review if they (1) were published in the English language,
(2) involved a face-to-face psychological intervention with a therapist (3) used no
treatment/waitlist, referral to Gamblers Anonymous (GA), or nonspecific treatment components
as control groups; (4) consisted of participants who met diagnosis for gambling disorder or its
subclinical symptoms according to an empirically validated assessment strategy; and (5) used
random assignment to two or more conditions. Studies were excluded if they (1) involved
pharmacotherapy as a study treatment condition; (2) involved telephone, Internet/computer, and
self-help/workbooks because these modes of treatment delivery were designed specifically for
individuals who have difficulty accessing accessing face-to-face treatments (Ginley, Rash, &
Petry, 2019); (3) did not assess gambling frequency, gambling intensity, gambling duration, or
gambling disorder symptom severity as outcomes variables; (4) did not report sufficient
information to calculate an effect size for treatment dose; (5) did not report sufficient information
to calculate an effect size for treatment efficacy; and (6) were review articles or descriptions of
planned study protocols. See Appendix A for a table of the studies that were reviewed at the fulltext level and the reasons for their exclusion. Appendix B includes a comprehensive list of
references for those studies.
Literature Search Procedure
The search of the literature and identification of relevant studies was conducted in two
stages. In stage 1, one reviewer independently determined if articles met inclusion/exclusion
criteria at the abstract level. In stage 2, two reviewers independently determined if articles met
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inclusion/exclusion criteria at the full-text level. Decisions for inclusion/exclusion were informed
using a codebook. All discrepancies were resolved through consensus, and when needed,
discussion with a third reviewer. Figure 1 displays the flowchart of this process.
The initial search yielded a total of 1,312 articles with 386 additional articles identified
through other sources. After the removal of duplicates, 1,522 articles underwent initial screening
at the stage 1 abstract level. Based on the stage 1 screening, 99 articles were identified for
possible inclusion and were then reviewed at the stage 2 full-text level. A total of 8 independent
articles were included in the systematic review and meta-analysis. Inter-rater agreement between
the two independent reviewers in the stage 2 full-text review was 97.0%.
Data Extraction and Quality Assessment
Descriptive information, sample characteristics, and treatment features were extracted
from each included study. Descriptive information that was extracted included study title,
reference, year of publication, and number of participants per condition. We extracted the
following sample characteristics: study location, description of study sample, mean age in years,
gender (% male), and race/ethnicity (% Caucasian). The treatment features we extracted were
treatment modality, treatment format (i.e., individual vs. group), control condition type,
treatment duration in weeks, and the offered treatment dose in number of sessions.
Descriptive information, sample characteristics, and treatment features were extracted
from each included study. Descriptive information that was extracted included study title,
reference, study location, and year of publication. The following sample characteristics were
extracted: description of how the study sample was recruited, the number of participants per
experimental condition, the participants’ mean age in years, gender (% male), and race/ethnicity
(% Caucasian). The treatment features extracted were treatment modality (e.g., CBT or
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motivational intervention), treatment format (i.e., individual vs. group), control condition type,
offered treatment dose in number of sessions, the received treatment dose, and when the
posttreatment assessment occurred.
Given a lack of standardized outcome measure for assessing the efficacy of psychological
treatments for gambling disorder, a variety of outcome indicators at posttreatment were
extracted. The following outcome indicators were considered: gambling frequency (e.g., number
of times gambled during past 30 days), gambling intensity (e.g., money wagered/spent on
gambling during the past 30 days), and gambling duration (e.g., minutes/hours gambled during
the past 30 days), and gambling disorder severity. The indicators of gambling disorder severity
were the gambling subscale of the Addiction Severity Index (ASI-G; Lesieur & Blume, 1992),
the Gambling Symptom Assessment Scale (G-SAS; Kim, Grant, Potenza, Blanco, & Hollander,
2009), the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale
(PG-YBOCS; Pallanti, DeCaria, Grant, Urpe, & Hollander, 2005), National Opinion Research
Center DSM-IV screen for gambling problems (NODS; Gerstein et al. 1999), the South Oaks
Gambling Screen (SOGS; Lesieur & Blume, 1987), and some measure of DSM symptoms. The
interrater agreement for data extraction of outcome was 90.3%.
The Cochrane risk of bias tool was used to assess for possible bias in the randomized
controlled trials that were included in this review (Higgins & Green, 2011). Four criteria were
used to assess study quality, including the assessment of random sequence generation, allocation
concealment, masking of outcome assessors, and analysis of intention to treat data/incomplete
outcome data. Selective outcome reporting was not rated because selective outcome reporting is
often conflated with nonreporting (Page & Higgins, 2016) and because most psychotherapy trials
are still not prospectively registered (Bradley, Rucklidge, & Mudler, 2017). Each risk of bias
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criteria was denoted with a high risk of bias, a low risk of bias, or an unclear risk of bias. For the
criterion about the masking of outcome assessors, studies that used entirely self-report
measurement were denoted. The assessment of validity for each study was conducted by two
independent reviewers and disagreements were resolved through discussion. The interrater
agreement between the two independent reviewers was 93.1%.
Data Analysis Plan
When information needed to conduct a meta-analysis was not reported in the original
publication, authors were contacted with requests for their data. A total of 14 studies could not be
included because they did not report sufficient statistical information to calculate an effect size
for dose or efficacy and because the authors of those studies could not fulfill data requests.
Comprehensive Meta-Analysis version 3.3070 was used to perform effect size
calculations. To meta-analyze received treatment dose, the weighted mean number of sessions
that participants attended for each face-to-face psychological treatment was calculated. To metaanalyze efficacy, between-group effect sizes were computed for each included study. Hedges’ g
was used because some studies had relatively small sample sizes. Using weights, effect sizes
were corrected for sampling bias (Hedges & Olkin, 1985). If there were multiple indicators of
outcome, the effect size for each indicator was extracted, summarized into one effect size, and
divided by the number of indicators (Borenstein, Hedges, Higgins, & Rothstein, 2009).
A random effects analysis was employed because considerable heterogeneity among the
studies was expected. There were a wide range of studies encompassing various treatment
modalities and comprising different samples included in this review. Heterogeneity was tested
with the Q-statistic to determine whether individual study effect sizes varied significantly around
the mean overall summary effect size of all studies (Hedges & Olkin, 1985). The magnitude of
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the variability or proportion of variance accounted for by true differences between studies was
then estimated with the I2 index and interpreted with the conventions of small (≤ 25%), medium
(≤ 50%), and large (≤ 75%; Higgins, Thompson, Deeks, & Altman, 2003). Significant
heterogeneity suggests that a random effects analysis is most appropriate and that between effect
size differences may be explained by moderators.
To determine the presence of a dose-response relation, random effects model meta
regression was performed. The mean number of treatment sessions attended (i.e., received
treatment dose) for each treatment was regressed onto the Hedges’ g values for each treatmentcontrol group comparison. Each study’s dropout rate was included in the meta-regression as a
control variable.
Separate meta-regressions were conducted for to test for other potential associations with
treatment efficacy. The publication date and participant demographics (i.e., age, percentage
male, and percentage Caucasian) for each study were regressed onto the Hedges’ g values for
each treatment-control group comparison.
Using several categorical variables, moderator analyses were performed to determine
differences in treatment efficacy. The categorical variables were study location, the type of study
sample used, and study quality (i.e., low or high quality studies). A random effects model and the
Q-statistic were used to test for potential moderators. A significant Q-value indicated a
difference between groups of the categorical variables for treatment efficacy. Because a total of
eight possible variables were tested in separate meta-regressions and subgroup analyses, a
Bonferroni-corrected alpha of .006 was used to indicate statistical significance.
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Results
Study and Sample Characteristics
Table 1 displays the 8 studies that were included in this review. Across the 8 studies, a
total of 592 participants were allocated to groups comprising 14 treatment-control post-treatment
comparisons. The sample sizes of the 8 studies ranged from 29 to 180 (M = 77.6, SD = 51.6,
median = 68.5). Most studies were conducted in Canada (k = 4, 50%), with the remaining studies
conducted in the United States (k = 3, 38%), and Australia (k = 1, 12%). The publication dates of
the 11 studies ranged from 1997 to 2016. The mean age of study participants ranged from 20.3 to
47.9 years (M = 39.5, SD = 8.7, median = 42.4). The percentage of males in the studies ranged
from 0% to 96% (M = 59.8, SD = 30.7, median = 59.5). The mean percentage of participants
who identified their race/ethnicity as Caucasian was 81.8% (SD = 16.3, median = 87.0), but it
should be noted that three studies did not report participants’ identified race/ethnicity.
Of the 14 treatment conditions across the 8 studies, the most frequently employed
treatment modality was CBT (37%), followed by some kind of motivational intervention (21%),
a combination of a motivational intervention and CBT (14%), brief advice (14%), cognitive
therapy, and twelve-step facilitation (7%). Seventy-one percent of the treatments were conducted
in individual format and 29% in group format. The 8 control conditions for the 14 treatment
conditions were either waitlists (62%) or an assessment only (38%). The posttreatment
assessments occurred between 0 to 12 weeks after the final treatment session.
Offered and Received Treatment Dose
Of the 14 treatments, the mean offered treatment dose was 9.4 sessions (SD = 9.0, median
= 8.0, range = 1 to 30). The weighted mean received treatment dose was 6.7 sessions (SD = 0.9),
95% CI [4.8, 8.6].
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Efficacy
The overall Hedges’ g value of the 14 treatment-control comparisons at posttreatment
was 0.64, 95% CI [0.39, 0.90], p < .001. Figure 2 displays a Forrest plot of the effect sizes for
face-to-face treatments versus control at posttreatment with all outcomes combined. The
treatments included in this meta-analysis were found to be highly heterogeneous in their effect
sizes, Q(13) = 35.96, p = .001, I2 = 63.85, with Hedges g values ranging from .14 to 1.82. The
high degree of heterogeneity indicates that the overall Hedges’ g value may not be the most
appropriate estimate for all treatments and that the effect sizes may differ depending on
moderators and covariates.
Meta Regressions
A meta-regression of Hedges’ g values was performed on the number of treatment
sessions attended to test the dose-response relation (Table 3). The meta regression was
statistically significant even when controlling for study dropout rates, p < .001. Figure 3 displays
a simple scatter plot of the regression of Hedges’s g values on the number of treatment sessions
attended. The regression line was relatively linear, indicating that as treatment dose increased,
treatment efficacy also increased.
Separate meta-regressions of treatment efficacy were also performed on the study’s
publication date, average age, the percentage of the sample that identified as male, and
percentage of the sample that identified as Caucasian. None of these meta-regressions were
statistically significant (Table 3).
Moderators of Treatment Efficacy
Comparisons were made to test differences in treatment efficacy when studies were
grouped by the sample used, study location, and study quality (Table 4). The only variable that
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significantly moderated treatment efficacy was study quality, where higher study quality was
indicative of lower treatment efficacy.
Assessment of Study Quality
Using the Cochrane Risk of Bias tool, it was determined that the quality of studies
included in this meta-analysis varied (Table 5). Three studies reported an adequate
randomization sequence generation while five did not. Two of the 8 studies reported an adequate
method of allocation concealment to study conditions. The allocation concealment of the
remaining six studies was unclear. Three studies adequately masked assessors who performed
evaluations of treatment outcome, while four had unclear procedures for masking assessors and
one used entirely self-report measurements. Five of the 8 studies reported complete outcome
data/employed intent-to-treat analyses, while three studies did not. Three studies met all four or
three study quality criteria and five met one or no study quality criteria.
Discussion
The aim of the present meta-analysis was to examine the relation between the received
treatment dose and efficacy in face-to-face psychological treatments for gambling disorder. A
total of 8 studies comprising 14 dose-efficacy comparisons across 592 participants were
identified. The results were inconsistent with the hypothesis that there was no dose-response
relation. Rather, the results of a meta-regression supported the presence of a dose-response
relation in face-to-face psychological treatments for gambling disorder. An examination of the
simple scatterplot revealed a positive, linear relation, in which treatment efficacy increased as the
number of treatment sessions attended increased. These results are consistent with the literature
on psychotherapy in general (Howard et al., 1986) and a limited number of studies on the
treatment of gambling disorder (Pfund et al., 2018; Shaffer et al., 2005; Smith et al., 2015). Thus,
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it is recommended that clinicians retain individuals in face-to-face psychological treatment for
gambling disorder as long as possible to maximize the possibility of a positive outcome.
The results of the present meta-analysis indicated that the weighted mean treatment dose
across face-to-face psychological treatments was 6.7 sessions. That treatment dose corresponded
to a treatment efficacy of .64 at 0-12 weeks posttreatment, which translates to a medium-sized
effect. That medium-sized effect is consistent with other meta-analyses of treatment-control
comparisons for psychological treatments of gambling disorder (Cowlishaw et al., 2012).
Unlike the general psychotherapy literature, there is presently no adequate treatment dose
for psychological treatment for gambling disorder. Petry and colleagues (2017) recently
recommended 6-8 sessions of CBT that integrates motivational interventions, but their
recommendation was informed by the overall quality of evidence rather than quantitative
indicators. The quantitative results supplied in this meta-analysis would suggest that individuals
would benefit from a greater dose than the 6-8 session dose recommended by Petry and
colleagues (2017). Future outcome studies should focus on what constitutes an adequate dose of
psychological treatment for gambling disorder while considering studies from the general
psychotherapy literature as examples. In the general psychotherapy literature, multiple variables
moderate the dose-response relation, such as outcome variables (Owen et al., 2016) and
treatment settings (Falkenström et al., 2016). Those future studies might bring data to bear on the
linearity of the dose-response relation in psychological treatment for gambling disorder.
The assessment of study quality indicated that there were few high-quality randomized
controlled trials on the psychological treatment for gambling disorder, so the present metaanalytic findings on the dose-response relation should be interpreted with caution. At the time
this article was written, no institute at the National Institute of Health (e.g., National Institute of
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Alcohol Abuse and Alcoholism, National Institute on Drug Abuse) incorporates gambling
disorder within its research mandate. Thus, research on the treatment of gambling disorder is
rarely funded at the federal level. In the United States, the National Center for Responsible
Gaming (NCRG) serves as the primary funding organization of gambling research. The lack of
federal funding for research on the psychological treatment of gambling disorder has resulted in
calls to action from researchers requesting funding from the National Institute of Health, as well
as the placement of gambling disorder within their institutes’ research mandates (Weinstock,
2018). Without well-funded research, it is likely that advancements in the treatment of gambling
disorder will be limited.
There are multiple limitations of the present meta-analysis that should be considered
when interpreting the results. One limitation is that the correlational results prohibit causal
conclusions about the relation between dose and efficacy in face-to-face psychological treatment
for gambling disorder. Randomized controlled trials, in which participants are randomly assigned
to varying doses of treatment would provide stronger evidence than the present meta-analysis
that increasing treatment doses cause better treatment responses. However, most of these studies
offered participants treatment doses between 1-6 sessions, which is smaller than the average dose
found in the present meta-analysis (Larimer et al., 2012; Petry et al., 2009; Toneatto, 2016).
Future research would benefit from high-quality randomized controlled trials designed to test the
efficacy of psychological treatment for gambling disorder at doses larger than six sessions.
Another limitation of this study is that the relation between dose and long-term response
could not be determined. Currently, few studies on the psychological treatment for gambling
disorder provide outcomes beyond the short-term posttreatment time frame (Petry et al., 2017).
Investigators have found some evidence for the reduction of gambling-related symptoms at 9-24
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months posttreatment (Diskin & Hodgins, 2009; Petry et al., 2006; Petry et al., 2008; Petry et al.,
2016), but more work must be done to test the relation between dose and long-term response of
psychological treatment for gambling disorder.
Despite the limitations of this meta-analysis, the results of this review can be used to
offer several recommendations for researchers and practicing clinicians. For researchers, it
would be advantageous to include the mean and standard deviation for the number of treatment
sessions attended in all treatment arms. Authors typically report dropout rates for treatment
studies, but those rates significantly vary depending on the measurement strategy (Pfund et al.,
2018; Swift, Callahan, & Levine, 2009; Swift & Greenberg, 2012;). Thus, the number of
treatment sessions attended may prove more informative than dropout rates.
For clinicians, CBT with or without MI is recommended for individuals with gambling
disorder. Clinicians should retain individuals in these treatments as long as possible, given that
the results of the meta-regression of dose on outcome suggested positive outcomes do not ceiling
out. To retain individuals in treatment, clinicians should consult the multiple empirically
supported strategies for preventing dropout from psychotherapy in general (Swift, Greenberg,
Whipple, & Kominiak, 2012). These strategies include, but are not limited to, fostering the
therapeutic alliance (Spencer, Goode, Penix, Trusty, & Swift, 2019), educating clients about
adequate treatment duration (Swift & Callahan, 2011), tailoring treatment to clients’ preferences
(Swift, Callahan, Cooper, & Parkin, 2018), and discussing expectations regarding roles and
behaviors in therapy (Reis & Brown, 2006). These strategies should be employed from the first
session, when clients in psychological treatment for gambling disorder are at the highest risk to
discontinue treatment (Pfund et al., 2018).
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Table 1.
Description of Studies Included in the Meta-Analysis of Dose and Efficacy in Psychological Treatments for Gambling Disorder

Study
location

Study
sample

Mean
age
(years)

Diskin & Hodgins (2009)

CAN

Community

45.0

57

nr

Dowling et al. (2007)

AUS

43.4

0

nr

Harris & Mazmanian (2016)

USA

Community
Internet
gamblers

34.2

53

72

Ladouceur et al. (2001)

CAN

Community

42.1

83

nr

Marceaux & Melville (2011)

USA

Community

47.9

40

87

Petry et al. (2008)

USA

Community

42.7

62

59

Petry et al. (2009)

USA

College
students

20.3

87

91

Sylvain et al. (1997)

CAN

Community

40.1

96

100

Study

%
male

%
White

Relevant study
conditions
MI
Assessment only
Individual CBT
Group CBT
Waitlist
Group CBT
Waitlist
Cognitive therapy
Waitlist
Group CBT
TSF
Waitlist
MET + CBT
MET
Brief advice
Assessment
MET + CBT
MET
Brief advice
Assessment
CBT
Waitlist

N per
group
42
39
14
17
25
16
16
35
29
15
11
7
40
55
37
48
21
30
32
34
14
15

Offered
treatment dose
(# of sessions)
1
12
12
12
≤ 20
16
16
4
1
1
4
1
1
≤ 30
-

When
posttreatment
assessment
occurreda
3-12
0
0
0
0
0
0
2
5
5
2
5
5
0
-

Notes. AUS = Australia; CAN = Canada; CBT = cognitive-behavioral therapy; GA = Gamblers’ Anonymous; MET = motivational
enhancement therapy; MI = motivational interviewing; nr = not reported; TSF = twelve-step facilitation; UK = United Kingdom; USA
= United States of America; aValues represent the number of weeks since the last session of treatment.
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Table 2.
Treatment Dose and Treatment Efficacy of Face-to-Face Psychological Treatments for Gambling Disorder

Study

Treatment type (n)

M (SD) of treatment
sessions attended
(received dose)

% of offered
dose
received

Posttreatment
effect size (g)

1.0 (0)

100

.26

Diskin & Hodgins (2009)

MI (42)

Dowling et al. (2007)

CBT (14)
Group CBT (17)

12.0 (0)
10.1 (1.6)

100
84

.68
.61

Harris & Mazmanian (2016)

Group CBT (16)

6.8 (3.2)

85

1.21

Ladouceur et al. (2001)

Cognitive therapy (35)

11.0 (5.2)

55

1.17

Petry et al. (2009)

Group CBT (18)
TSF (11)
MET + CBT (40)
MET (55)
Brief advice (37)
MET + CBT (21)
MET (30)
Brief advice (32)

14.9 (1.8)
14.7 (1.7)
2.1 (1.5)
.94 (.23)
1.0 (0)
2.3 (1.4)
1.0 (0)
1.0 (0)

93
92
52
94
100
58
100
100

1.73
1.62
.25
.20
.39
.14
.41
.36

Sylvain et al. (1997)

CBT (14)

16.7 (5.7)

56

1.82

Marceaux & Melville (2011)

Petry et al. (2008)

Outcomes in effect
size calculation
Gx frequency
Gx intensity
Gx frequency
Gx intensity
Gx duration
DSM-IV-TR
Gx frequency
DSM-IV
Gx frequency
Gx intensity
Gx duration
DSM-IV
Gx frequency
Gx intensity
ASI-G
Gx intensity
ASI-G
Gx intensity
Gx frequency
DSM-III
SOGS
Gx frequency
Gx intensity
Gx duration

Notes. ASI-G = Gambling Scale of the Addiction Severity Index; CBT = cognitive-behavioral therapy; DSM = Diagnostic and
Statistical Manual of Mental Disorders; GA = Gamblers’ Anonymous; Gx = gambling; MET = motivational enhancement therapy; MI
= motivational interviewing; SOGS = South Oaks Gambling Screen; TSF = twelve-step facilitation
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Table 3.
Results from Meta-Regressions of Dose, Publication Date, Age, Gender, and Race on Treatment
Efficacy
Point
estimate

95% CI

Z-value

p-value

Slope

.08

.05, .12

5.34

< .001

Dropout

-.00

-.01, .00

-.39

.70

Intercept

.20

-.01, .41

1.85

.06

-.02

-.11, .06

-.53

.60

46.80

-123.44, 217.03

.54

.59

Slope

.02

-.01, .06

1.46

.14

Intercept

-.15

-1.31, 1.01

-.25

.80

Slope (Male vs. female)

-.01

-.03, .01

-1.04

.30

Intercept

1.40

-.01, 2.81

1.95

.05

Slope (White vs. non-White)

.01

-.00, .04

1.53

.13

Intercept

-.61

-2.27, 1.05

-.72

.47

Variable (# of treatments)
Dose (14)

Publication date (14)
Slope
Intercept
Age (14)

Gender: % Male (14)

Race: % White (10)

24

Table 4.
Results from Subgroup Analyses of Study Location, Study Sample, and Study Quality Moderators
on Treatment Efficacy

Moderator (# of treatments)

Hedges’ g

95% CI

Study location (14)
Australia (2)

.64

.16, 1.12

Canada (4)

1.06

.38, 1.74

United States (8)

.43

.17, .69

Study sample (14)
College students (3)

.31

.02, .60

Community (10)

.74

.40, 1.07

Internet gamblers (1)

1.21

.46, 1.96

Study qualitya (14)
Low (7)

1.14

Q-value

p-value

3.11

.21

6.74

.03

20.12

< .001

.82, 1.52

High (7)
.29
.12, .45
Studies were considered “low” quality if they had two or fewer indicators of low risk of bias
(+), whereas studies were considered high quality if they had three or more indicators of low risk
of bias.
a
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Table 5.
Assessment of Study Quality for the 8 Studies Included in the Meta-Analysis
Randomization
Sequence
Generation

Allocation
Concealment

Masking of
Assessors

Complete
Outcome Data

Diskin & Hodgins (2009)

+

?

+

+

Dowling et al. (2007)

?

?

?

+

Harris & Mazmanian (2016)

-

?

- (sr)

+

Ladouceur et al. (2001)

?

?

?

-

Marceaux & Melville (2011)

?

?

?

-

Petry et al. (2008)

+

+

+

+

Petry et al. (2009)

+

+

+

+

Study

Sylvain et al. (1997)
?
?
?
Notes. + = low risk of bias; – = high risk of bias; ? = unclear risk of bias; sr = the study employed
self-report measures only
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Records identified through
database searching
(k = 1,312)

Additional records identified
through other sources
(k = 386)

Records after duplicates removed
(k = 1,522)

Records excluded
(k = 1,423)

Abstracts screened
(k = 1,522)

Excluded full-text articles with primary
reasons for exclusion (k = 91):

Full-text articles
assessed for eligibility
(k = 99)

Involved pharmacotherapy (k = 28)
Not face-to-face interventions (k = 19)
Insufficient statistical information (k = 14)
No random assignment (k = 11)
Inappropriate control group (k = 10)
Not a treatment study (k = 5)
No problem/pathological/disordered
gambling (k = 3)
No treatment outcomes related to gambling
(k = 1)

Studies included
(k = 8)

Figure 1.
Study flowchart for identification of studies to be included in this review.
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Study name

Subgroup within study

Statistics for each study
Hedges's
g

Diskin & Hodgins (2009)
Dowling et al. (2007)
Dowling et al. (2007)
Harris & Mazmanian (2016)
Ladouceur et al. (2001)
Marceaux & Melville (2011)
Marceaux & Melville (2011)
Petry et al. (2008)
Petry et al. (2008)
Petry et al. (2008)
Petry et al. (2009)
Petry et al. (2009)
Petry et al. (2009)
Sylvain et al. (1997)

MI
CBT
Group CBT
Group CBT
Cognitive Therapy
Group CBT
Twelve-Step Facilitation
Brief Advice
MET
MET + CBT
Brief Advice
MET
MET + CBT
Cognitive Therapy

Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined

0.260
0.678
0.610
1.213
1.173
1.733
1.618
0.393
0.200
0.250
0.357
0.414
0.140
1.822
0.643

Lower
limit

-0.175
-0.040
-0.038
0.463
0.625
0.672
0.570
-0.038
-0.185
-0.168
-0.125
-0.077
-0.397
0.982
0.390

Upper
limit

0.694
1.395
1.259
1.964
1.720
2.793
2.665
0.824
0.585
0.669
0.840
0.905
0.677
2.662
0.895

Hedges's g and 95% CI

p-Value

0.241
0.064
0.065
0.002
0.000
0.001
0.002
0.074
0.309
0.240
0.147
0.098
0.610
0.000
0.000
-3.00

-1.50
Fav ors Control

0.00

1.50

3.00

Fav ors Treatment

Figure
Meta2.Analysis
Forrest plot of effect sizes of face-to-face psychological treatments for gambling disorder versus control at posttreatment with all
outcomes combined
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3.00

Hedges's g (Treatment Efficacy)

2.50

2.00

1.50

1.00

0.50

0.00

-0.50

-1.00
-2.0

0.0

2.0

4.0

6.0

8.0

10.0

12.0

14.0

16.0

18.0

20.0

Treatment Sessions Attended (Received Dose)

Figure 3.
Simple scatterplot of dose and efficacy in face-to-face psychological treatments for gambling
disorder
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Appendix A
Table of studies that were excluded from the review with the primary reason for their exclusion
Primary reason for exclusion

Study authors
(year)
Abbott et al.
(2018)
Berlin et al.
(2013)
Black et al.
(2007)
Blanco et al.
(2002)
Blaszczynski
et al. (2005)
Blaszczynski
et al. (1991)
Bouchard et al.
(2017)
Boudreault et
al. (2018)
Bucker et al.
(2018)
Campos et al.
(2016)
Canale et al.
(2016)

Involved
pharmacotherapy
(k = 28)

Not
Insufficient
face-tostatistical
face
information
(k = 19)
(k = 14)

No random
assignment
(k = 11)

X
X
X
X
X
X
X
X
X
X
X

30

Inappropriate
control group
(k = 10)

Not a
treatment
study
(k = 5)

No problem,
pathological,
disordered
gamblers
(k = 3)

No
outcomes
related to
gambling (k
= 1)

Carlbring et al.
(2010)
Carlbring &
Smit (2008)
Casey et al.
(2017)
Celio &
Lisman (2014)
Champine &
Petry (2010)
Cunningham et
al. (2012)
Cunningham et
al. (2009)
Dannon et al.
(2011)
Dannon et al.
(2005a)
Dannon et al.
(2005b)
de Brito et al.
(2017)
Dickerson et
al. (1990)
Doiron &
Nicki (2007)
Echeburua et
al. (1996)
Echeburua et
al. (2000)
Echeburua et
al. (2011)

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

31

Grant et al.
(2011)
Grant et al.
(2009)
Grant et al.
(2008)
Grant et al.
(2007)
Grant et al.
(2003)
Grant et al.
(2014)
Grant et al.
(2010)
Grant et al.
(2006a)
Grant et al.
(2006b)
Grant et al.
(2017)
Hodgins et al.
(2001)
Hodgins et al.
(2004)
Hodgins et al.
(2007)
Hodgins et al.
(2009)
Hollander et al.
(1998)
Hollander et al.
(2000)

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

32

Hollander et al.
(2005)
Jimenez‐
Murcia et al.
(2007)
Jimenez‐
Murcia et al.
(2012a)
JimenezMurcia et al.
(2012b)
JiménezMurcia et al.
(2017)
Josephson et
al. (2016)
Kim et al.
(2001)
Kim et al.
(2002)
Korman et al.
(2008)
Kovanen et al.
(2016)
LaBrie et al.
(2012)
Ladoceur et al.
(2003)
Larimer et al.
(2012)
Linardatou et
al. (2014)

X
X

X

X

X
X
X
X
X
X
X
X
X
X

33

Lee &
Awosago
(2015)
Luquiens et al.
(2016)
Martens et al.
(2015)
McConaghy et
al. (1988)
McConaghy et
al. (1983)
McConaghy et
al. (1991)
McElroy et al.
(2008)
Melville et al.
(2004)
Milton et al.
(2002)
Myrseth et al.
(2009)
Myrseth et al.
(2011)
Neighbors et
al. (2015)
Oakes et al.
(2012)
Oei et al.
(2010)
Oei et al.
(2018)
Pallanti et al.
(2002)

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
34

Petry et al.
(2010)
Petry et al.
(2006a)
Petry et al.
(2006b)
Petry et al.
(2007)
Petry et al.
(2016)
Saiz-Ruiz et al.
(2005)
Shaffer et al.
(2005)
Smith et al.
(2015)
Smith et al.
(2018)
Stea et al.
(2015)
Stewart et al.
(2016)
Thomas et al.
(2010)
Tolchard et al.
(2006)
Toneatto
(2016)
Toneatto et al.
(2009)
Tse et al.
(2013)

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

35

Wong et al.
(2015)

X
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Appendix B
References for Excluded Studies (in alphabetical order)
Abbott, M., Hodgins, D. C., Bellringer, M., Vandal, A. C., Palmer Du Preez, K., Landon, J.,
Sullivan, S., Rodda, S., & Feigin, V. (2018). Brief telephone interventions for problem
gambling: a randomized controlled trial. Addiction, 113, 883-895.
Berlin, H. A., Braun, A., Simeon, D., Koran, L. M., Potenza, M. N., McElroy, S. L., ... &
Hollander, E. (2013). A double-blind, placebo-controlled trial of topiramate for pathological
gambling. The World Journal of Biological Psychiatry, 14(2), 121-128.
Black, D. W., Arndt, S., Coryell, W. H., Argo, T., Forbush, K. T., Shaw, M. C., ... & Allen, J.
(2007). Bupropion in the treatment of pathological gambling: a randomized, double-blind,
placebo-controlled, flexible-dose study. Journal of Clinical Psychopharmacology, 27(2),
143-150.
Blanco, C., Petkova, E., Ibáñez, A., & Sáiz-Ruiz, J. (2002). A pilot placebo-controlled study of
fluvoxamine for pathological gambling. Annals of Clinical Psychiatry, 14(1), 9-15.
Blaszczynski, A., Drobny, J., & Steel, Z. (2005). Home-based imaginal desensitisation in
pathological gambling: Short-term outcomes. Behaviour Change, 22(1), 13-21.
Blaszczynski, A., McConaghy, N., & Frankova, A. (1991). Control versus abstinence in the
treatment of pathological gambling: A two to nine year follow‐up. British Journal of
Addiction, 86(3), 299-306.
Bouchard, S., Robillard, G., Giroux, I., Jacques, C., Loranger, C., St-Pierre, M., ... & Goulet, A.
(2017). Using virtual reality in the treatment of gambling disorder: The development of a
new tool for cognitive behavior therapy. Frontiers in Psychiatry, 8, 27.
Boudreault, C., Giroux, I., Jacques, C., Goulet, A., Simoneau, H., & Ladouceur, R. (2018).
Efficacy of a self-help treatment for at-risk and pathological gamblers. Journal of Gambling
Studies, 34(2), 561-580.
Bücker, L., Bierbrodt, J., Hand, I., Wittekind, C., & Moritz, S. (2018). Effects of a depressionfocused internet intervention in slot machine gamblers: A randomized controlled trial. PloS
One, 13(6), e0198859.
Campos, M. D., Rosenthal, R. J., Chen, Q., Moghaddam, J., & Fong, T. W. (2016). A self-help
manual for problem gamblers: The impact of minimal therapist guidance on
outcome. International Journal of Mental Health and Addiction, 14(4), 579-596.
Canale, N., Vieno, A., Griffiths, M. D., Marino, C., Chieco, F., Disperati, F., ... & Santinello, M.
(2016). The efficacy of a web-based gambling intervention program for high school students:
A preliminary randomized study. Computers in Human Behavior, 55, 946-954.
Carlbring, P., Jonsson, J., Josephson, H., & Forsberg, L. (2010). Motivational interviewing
versus cognitive behavioral group therapy in the treatment of problem and pathological
gambling: A randomized controlled trial. Cognitive Behaviour Therapy, 39(2), 92-103.
Carlbring, P., & Smit, F. (2008). Randomized trial of internet-delivered self-help with telephone
support for pathological gamblers. Journal of Consulting and Clinical Psychology, 76(6),
1090-1094.
Casey, L. M., Oei, T. P., Raylu, N., Horrigan, K., Day, J., Ireland, M., & Clough, B. A. (2017).
Internet-based delivery of cognitive behaviour therapy compared to monitoring, feedback
and support for problem gambling: A randomised controlled trial. Journal of Gambling
Studies, 33(3), 993-1010.
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Celio, M. A., & Lisman, S. A. (2014). Examining the efficacy of a personalized normative
feedback intervention to reduce college student gambling. Journal of American College
Health, 62(3), 154-164.
Champine, R. B., & Petry, N. M. (2010). Pathological gamblers respond equally well to
cognitive‐behavioral therapy regardless of other mental health treatment status. The
American Journal on Addictions, 19(6), 550-556.
Cunningham, J. A., Hodgins, D. C., Toneatto, T., & Murphy, M. (2012). A randomized
controlled trial of a personalized feedback intervention for problem gamblers. PloS
One, 7(2), e31586.
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blind-rater study. Journal of Clinical Psychopharmacology, 25(6), 593-596.
Dannon, P. N., Lowengrub, K., Gonopolski, Y., Musin, E., & Kotler, M. (2005b). Topiramate
versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater
comparison study. Clinical Neuropharmacology, 28(1), 6-10.
de Brito, A. M. C., de Almeida Pinto, M. G., Bronstein, G., Carneiro, E., Faertes, D., Fukugawa,
V., ... & Tavares, H. (2017). Topiramate combined with cognitive restructuring for the
treatment of gambling disorder: A two-center, randomized, double-blind clinical
trial. Journal of Gambling Studies, 33(1), 249-263.
Dickerson, M., Hinchy, J., & England, S. L. (1990). Minimal treatments and problem gamblers:
A preliminary investigation. Journal of Gambling Studies, 6(1), 87-102.
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